UltraGreen.ai’s post-IPO performance is an important gauge of investor interest
It represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse
Add BT as a preferred source
[SINGAPORE] After years of lamenting the lack of high-tech, growth-focused companies on the Singapore Exchange (SGX), investors are getting their wish granted with the upcoming debut of UltraGreen.ai.
The company develops fluorescence-guided surgery technology, offers fluorescence imaging services and supplies indocyanine green dyes used in surgical procedures. More importantly, it represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse.
UltraGreen.ai is laying the foundation for success with a high-powered board. Kwa Chong Seng, former SGX and ST Engineering chairman, is the non-independent non-executive chairman. Hsieh Fu Hua, former SGX CEO and once a director at Grab, is the lead independent director.
TRENDING NOW
Think twice about rebuilding that old landed property into a super-big house to max out GFA
SpaceX’s US$1.75 trillion IPO: How retail investors, including those in Singapore, can buy shares
Battle for Asia’s ultra-rich: ‘Singapore can’t afford to keep losing clients to Dubai, Hong Kong’
Tech rout sweeps Asia as AI rally jitters spark sell-off
